Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
8 May 24
8-K
Entry into a Material Definitive Agreement
3 May 24
8-K
Departure of Directors or Certain Officers
11 Apr 24
EFFECT
Notice of effectiveness
1 Apr 24
10-K
2023 FY
Annual report
28 Mar 24
POS AM
Prospectus update (post-effective amendment)
26 Mar 24
8-K
Departure of Directors or Certain Officers
26 Jan 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
14 Nov 23
8-K
Departure of Directors or Certain Officers
1 Sep 23
S-8
Registration of securities for employees
10 Aug 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
8-K
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update
10 Aug 23
8-K
Departure of Directors or Certain Officers
2 Aug 23
8-K
Regulation FD Disclosure
27 Jul 23
8-K
Other Events
24 Jul 23
8-K
Talis Biomedical Announces 1-for-15 Reverse Stock Split
5 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
9 Jun 23
8-K
Departure of Directors or Certain Officers
23 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
8-K
Talis Biomedical Announces Business Update and First Quarter 2023 Financial Results
11 May 23
8-K
Other Events
8 May 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
PRE 14A
Preliminary proxy
18 Apr 23
8-K
Departure of Directors or Certain Officers
11 Apr 23
10-K
2022 FY
Annual report
22 Mar 23
8-K
Talis Announces Fourth Quarter and Full Year 2022 Financial Results
22 Mar 23
8-K
Departure of Directors or Certain Officers
10 Mar 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
25 Jan 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
8-K
Talis Biomedical Reports Third Quarter 2022 Financial Results
3 Nov 22
8-K
Other Events
12 Aug 22
S-8
Registration of securities for employees
2 Aug 22
10-Q
2022 Q2
Quarterly report
2 Aug 22
8-K
Talis Biomedical Provides Business Update and Reports Second Quarter Financial Results
2 Aug 22
8-K
Departure of Directors or Certain Officers
10 Jun 22
8-K
Departure of Directors or Certain Officers
2 Jun 22
EFFECT
Notice of effectiveness
25 May 22
424B3
Prospectus supplement
24 May 22
Latest ownership filings
SC 13G/A
GREENLIGHT CAPITAL INC
14 Feb 24
4
Andrew A Lukowiak
2 Aug 23
3
Andrew A Lukowiak
2 Aug 23
4
Rebecca Markovich
18 Jul 23
4
JULIAN BAKER
13 Jun 23
4
Randal W. Scott
12 Jun 23
4
Matthew L. Posard
12 Jun 23
4
Kimberly J Popovits
12 Jun 23
4
Melissa Gilliam
12 Jun 23
4
Rustem F. Ismagilov
12 Jun 23
4
Heinrich Dreismann
12 Jun 23
4
Heinrich Dreismann
23 May 23
3
Heinrich Dreismann
23 May 23
3
Rebecca Markovich
25 Apr 23
4
John Roger Moody Jr
11 Apr 23
4
Robert J. Kelley
11 Apr 23
SC 13D/A
BAKER BROS. ADVISORS LP
10 Mar 23
3
Raymond Cheong
10 Mar 23
SC 13G/A
ArrowMark Colorado Holdings LLC
15 Feb 23
SC 13G/A
GREENLIGHT CAPITAL INC
14 Feb 23
SC 13G/A
ArrowMark Colorado Holdings LLC
12 Sep 22
4
Randal W. Scott
13 Jun 22
4
Matthew L. Posard
13 Jun 22
4
Kimberly J Popovits
13 Jun 22
4
Rustem F. Ismagilov
13 Jun 22
4
Melissa Gilliam
13 Jun 22
4
JULIAN BAKER
13 Jun 22
SC 13D/A
BAKER BROS. ADVISORS LP
13 Jun 22
4
John Roger Moody Jr
2 Jun 22
4
Robert J. Kelley
2 Jun 22
SC 13G
GREENLIGHT CAPITAL INC
14 Feb 22
SC 13G/A
ArrowMark Colorado Holdings LLC
14 Feb 22
SC 13G/A
Boxer Capital, LLC
14 Feb 22
4
Robert J. Kelley
9 Dec 21
4
Brian J Blaser
2 Dec 21
3
Brian J Blaser
2 Dec 21
4
JULIAN BAKER
19 Nov 21
4
John Roger Moody Jr
5 Oct 21
4
Douglas Liu
5 Oct 21
4
Robert J. Kelley
5 Oct 21